| With the unique developmental and physiological differences of children, performing clinical research on this population is essential. The EpiCor postbiotic team at Cargill recently completed a human clinical trial that sought to investigate how EpiCor, delivered via gummy format, may help support the immune system of children ages 4-12. We are less than two weeks away from our webinar on October 2nd at 10am CDT; register now to learn the exciting findings from the newest clinical study! | 